Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AbbVie Seeks Dismissal of Androgel Lawsuits as Bellwether Selections Approach July 9, 2015 Austin Kirk Add Your Comments As the U.S. District Judge presiding over all federal testosterone lawsuits plans to meet with the parties today during a status conference, AbbVie is seeking the dismissal of certain Androgel lawsuits that may be eligible for inclusion in the bellwether program. There are currently more than 1,750 product liability lawsuits pending in a federal multidistrict litigation (MDL) involving men who suffered heart attacks, strokes, blood clots and other injuries allegedly caused by side effects of testosterone replacement therapy. While most of the cases involve use of Androgel, which is the most widely used low testosterone drug, the MDL also includes cases involving other products, such as Axiron, Testim, AndroDerm and other creams, injections and capsules. Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION For coordinated pretrial proceedings, the cases are centralized before U.S. District Judge Matthew Kennelly in the Northern District of Illinois to avoid duplicative discovery into common issues in the cases, prevent conflicting rulings from different courts and to serve the convenience of the parties, witnesses and the courts. Judge Kennelly has previously ordered the parties to select a small group of Androgel cases to be part of a “bellwether” pool, which will go through case-specific discovery in preparation for a series of early trial dates late next year. Next month, the parties are required to submit a proposal for selecting a group of 32 cases from about 700 lawsuits over Androgel that are eligible for these bellwether trials. However, Abbvie indicates that many of the plaintiffs have submitted “materially deficient” Plaintiff Fact Sheets (PFS), preventing the entire pool of cases from being complete and well defined. In a motion (PDF) filed this week, AbbVie asked Judge Kennelly to dismiss with prejudice up to 169 lawsuits if plaintiffs do not address deficiencies in their PFS by August 14. “Until there is a defined and complete pool of known cases that is not capable of being “gamed”… the Court will be unable to establish and then implement the process by which it picks the 32 cases to be worked up for potential bellwether trial,” said the drug maker in the motion. In a joint status report (PDF) filed the same day, the Plaintiffs’ Steering Committee (PSC) responded to AbbVie’s request. “Upon subsequent review of the alleged deficiencies by counsel in the underlying cases, it is apparent that the overwhelming majority of the alleged deficiencies are without basis,” the plaintiffs’ attorneys noted. “The PSC is concerned that AbbVie is attempting to use the PFS and related deficiency process as a tactical sword in the bellwether process, rather than as a fact finding and discovery tool to gather information and collect plaintiffs’ medical records with authorizations.” The issue is likely to be addressed during a status conference today before Judge Kennelly. Androgel Bellwether Trials The bellwether cases are designed to be representative of large numbers of other claims in the litigation, with the bellwether trials providing a gauge for how juries may respond to certain evidence and testimony that is likely to be similar to what will be offered by many plaintiffs. All of the complaints involve allegations that AbbVie and other testosterone drug makers failed to adequately research the medications or warn that certain men may face an increased risk of suffering a heart attack, stroke, pulmonary embolism, deep vein thrombosis or sudden death while using the testosterone drugs. The manufacturers have also been accused of encouraging men to seek prescriptions for “low T” if they suffer any number of general symptoms common among most men as they age, such as decreased strength, lack of energy and reduced sex drive. By October 31, the bellwether pool is expected to be reduced to eight AndroGel cases dealing with thromboembolism cases and eight cardiovascular injury cases, which will then go through case specific discovery. By March 1, 2016, the court is expected to choose three thromboembolism cases and three heart attack cases that will go before juries. Individual trial dates for the three thromboembolism cases have been scheduled to begin October 31, 2016, December 5, 2016 and January 9, 2017. The three cases involving cardiovascular injuries are scheduled to begin on February 13, 2017, March 20, 2017 and April 24, 2017. While the outcomes of these early trial dates are not binding on other cases, they may influence eventual Androgel settlement negotiations. Following the bellwether process, if AbbVie fails to resolve large numbers of cases, they may face hundreds of individual trial dates spread throughout the country. Tags: AbbVie, AndroGel, Heart Attacks, Strokes, Testosterone, Testosterone Gel Image Credit: | More Testosterone Lawsuit Stories Link Between Testosterone Drugs and Heart Risks Not Found in New Study June 19, 2023 Study’s Findings Question Link Between Testosterone Drugs and Blood Clots October 26, 2021 New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: yesterday) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025) 12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (Posted: 2 days ago) A dozen hair dye lawsuits over bladder cancer risks have been consolidated under one California state judge for coordinated pretrial proceedings. MORE ABOUT: HAIR DYE LAWSUITJudge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025) BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: 3 days ago) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)
New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: yesterday) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (Posted: 2 days ago) A dozen hair dye lawsuits over bladder cancer risks have been consolidated under one California state judge for coordinated pretrial proceedings. MORE ABOUT: HAIR DYE LAWSUITJudge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)
BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: 3 days ago) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)